Valproic acid–induced hyperammonemia: Incidence, clinical significance, and treatment management

INTRODUCTION: Valproic acid (VPA)–induced hyperammonemia poses several clinical challenges in psychiatric medicine. The reported incidence of this adverse effect varies widely across the literature. Furthermore, practitioners treat hyperammonemia in asymptomatic patients although studies suggest thi...

Descripción completa

Detalles Bibliográficos
Autores principales: Baddour, Elisa, Tewksbury, Ashley, Stauner, Nick
Formato: Online Artículo Texto
Lenguaje:English
Publicado: College of Psychiatric & Neurologic Pharmacists 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6007737/
https://www.ncbi.nlm.nih.gov/pubmed/29955549
http://dx.doi.org/10.9740/mhc.2018.03.073

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6007737/
https://www.ncbi.nlm.nih.gov/pubmed/29955549
http://dx.doi.org/10.9740/mhc.2018.03.073

Ejemplares similares